Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Comment by SouthernTierTomon Apr 15, 2022 6:22pm
194 Views
Post# 34606990

RE:Will May flowers bring "Financing $howers"? ...

RE:Will May flowers bring "Financing $howers"? ...The cash position now must be closer to 2M than 3M.  When the last "surprising" raise ocurred the cash was at about 1.6M if memory serves.  Many clinical stage co's have had "tempered burn$" with covid 19 playing a stunting role in trial recruitment.  I was hoping to see the 35 cent CAD warrants from the last raise come into play, but not with a 32 cent CAD share price.  Wondering how low the kitty goes before a raise becomes reality?

Just thinking out loud as i am looking for a retail enrty point...

Important to share these things with fellow retailers before, we get a dose of the last "$urprise"

Hmmmm...

Nobody rolled into Bethesda on "fume$" ...just doesn't happen...SEE FDA costs to FULL approval.

Tick tock tick tock...bullboard posters here have history of escortation in these matters...

Bear in mind the last PUMP in the mid 50's CAD prior to the 30 cent placement with 35 cent warrants

Hmmmm...

The kitty has to be running low, especially once trial activity starts to ramp up...shocking nobody discusses these most important of details.

I love the Auntie Ruth-erin discussion..VERY meaning-full..of something..you decide.

GLTA,
Beech watche
<< Previous
Bullboard Posts
Next >>